Harvard Medical School, United States
Disclosure information not submitted.
SP04A - A Scoping Review of Key Use Cases for Artificial Intelligence to Reduce the Frequency of Adverse Drug Events
Tuesday, August 24, 20213:30 PM – 4:45 PM US Eastern Time